`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`MEDTRONIC, INC., MEDTRONIC VASCULAR, INC.,
`and MEDTRONIC COREVALVE, LLC
`Petitioner
`
`v.
`
`TROY R. NORRED, M.D.
`Patent Owner
`______________________
`
`Case IPR2014-00110
`Patent 6,482,228
`______________________
`
`PATENT OWNER REPLY IN SUPPORT OF MOTION TO AMEND
`PURSUANT TO 37 C.F.R. § 42.121
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` iii
`
` iv
`
` 1
`
` 2
`
` 2
`
` 3
`
`
`
`
`
`Exhibit List
`
`Table of Authorities
`
`I.
`
`TABLE OF CONTENTS
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The Amendments Do Not Enlarge the Scope of the Claim and
`Are Responsive to a Ground of Unpatentability
`
`
`
`Claim Constructions Are Not Needed for New Terms
`
`
`II.
`
`III. Norred Provided Support for the Substitute Claim
`
`IV. Norred Showed that the Substitute Claim is Patentable
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` ii
`
`
`
`
`
`
`
`
`
`EXHIBIT LIST
`
`Exhibit Description
`
`Exhibit No.
`
`U. S. Patent No. 6,482,228 to Norred
`
`U. S. Patent No. 6,440,164
`
`U. S. Patent No. 6,245,101 to Drasler et al
`Transcript of deposition of Timothy Titus Catchings, M.D.
`conducted on October 7, 2014
`Transcript of deposition of Troy R. Norred, M.D. conducted on
`October 8, 2014
`GermanPatent DE19546692 to Figulla – Filed application with
`translation
`Declaration of Thomas Vassiliades, Jr., M.D.
`
`Percutaneous Aortic Valve Replacement
`
`Declaration of Troy R. Norred, M.D.
`
`Declaration of Timothy Catchings, M.D.
`
`U. S. Patent No. 6,454,799 to Schreck
`
`U. S. Patent No. 5,957,949 to Leonhardt et al.
`
`U. S. Patent No. 4,084,268 to Ionescu et al.
`
`U. S. Patent No. 4,477,930 to Totten et al.
`
`U. S. Patent No. 6,059,827 to Fenton, Jr.
`
`U. S. Patent No. 6,139,575 to Shu et al.
`
`U. S. Patent No. 5,411,552 to Anderson et al.
`
`U. S. Patent No. 5,855,597 to Jayaraman
`
`U. S. Patent No. 6,425,916 to Garrison et al.
`
`U. S. Patent No. 6,458,153 to Bailey et al.
`
`German Patent DE19857887
`
`Schreck illustration to Catchings Deposition (Ex. 1009)
`
`Schreck illustration to Catchings Deposition (Ex. 1009)
`
`Schreck illustration to Catchings Deposition (Ex. 1009)
`
`DiMatteo illustration to Catchings Deposition (Ex. 1009)
`
` iii
`
`1001
`
`1003
`
`1008
`
`1009
`
`1010
`
`1013
`
`1020
`
`2010
`
`2093
`
`2095
`
`2098
`
`2099
`
`2101
`
`2102
`
`2113
`
`2114
`
`2116
`
`2119
`
`2122
`
`2123
`
`2126
`
`2129
`
`2130
`
`2131
`
`2132
`
`
`
`
`
`DiMatteo illustration to Catchings Deposition (Ex. 1009)
`
`DiMatteo illustration to Catchings Deposition (Ex. 1009)
`
`
`
`
`
`2133
`
`2134
`
` iv
`
`
`
`
`
`TABLE OF AUTHORITIES
`
`
`Cf. Beckson Marine, Inc. v. NFM, Inc.,
`
`144 Fed. Appx. 862 (Fed. Cir. 2005)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 2
`
` v
`
`
`
`
`
`I.
`
`The Amendments do not Enlarge the Scope of the Claim
`and are Responsive to a Ground of Unpatentability
`
`Original claim 16 includes a means-plus-function limitation, “means for mount-
`
`ing said first open end of said membrane about said aperture.” (Ex. 1001, 8:7-8.) The
`
`Board construed this to mean the membrane is “hingedly secured” or “hingedly at-
`
`tached” to the aperture of the ring. Paper 10 at 10. Claim 25 adopts this construct-
`
`ion, replacing the means-plus-function limitation with language specifying the mem-
`
`brane is “hingedly secured about said aperture of said ring member.” Paper 26 at 2.
`
`Petitioner argues Claim 16 must be interpreted to include “fingers or arms” be-
`
`cause these structures are necessary to perform the required function. Petitioner’s Opp.
`
`at 4. Because the proposed amendment does not include “fingers or arms,” it pur-
`
`portedly broadens the scope of the claim. Id. at 6. This argument is misplaced.
`
`Claim 16 is not limited to embodiments that include fingers or arms. It also
`
`encompasses cadaver and porcine valves as depicted in Figs. 18 and 19. (Ex. 1001,
`
`2:49-51, 5:63-6:8; see also Paper 10 at 7, membrane). In these embodiments, the mem-
`
`brane attaches directly to the ring aperture and functions as a hinge, allowing the valve
`
`to move between a closed position and an open position. (Ex. 2095, ¶ 35.) This is
`
`how natural valves work, as Petitioner’s own expert acknowledges. (IPR20140-00111,
`
`Ex. 1020, ¶¶ 23-28.) No other structures are necessary to perform the required funct-
`
`ion. Accordingly, no other structures must be included in the proposed amendment
`
`to prevent it from broadening the claim. Cf. Beckson Marine, Inc. v. NFM, Inc., 144
`
`
`
`1
`
`
`
`
`
`Fed. Appx. 862 (Fed. Cir. 2005) (“means hingedly connecting” must be interpreted
`
`under § 112, ¶ 6 because the “means” language was used and no specific structure was
`
`identified).
`
`II. Claim Constructions Are Not Needed for New Terms
`
`The terms in Claim 25 should be given their ordinary and customary meanings,
`
`consistent with the Specification, as those terms would be understood by one of ordi-
`
`nary skill in the art. Special claim constructions are not required because the terms are
`
`not subject to dispute. Petitioner attempts to create a dispute regarding the term “pli-
`
`able” by suggesting that Drs. Catchings and Norred disagree about whether super-
`
`elastic material as used in DiMatteo (Ex. 1003) can be pliable. This suggestion is mis-
`
`leading. Dr. Catchings testified that a superelastic stent is a stent that is “easily mal-
`
`leable … [and] can be twisted, turned, moved into shape easily without permanent de-
`
`formity.” (Ex. 1009, 181:10-15.) Dr. Norred did not disagree with this point. (Ex.
`
`1010, 84:5-85:5.) Instead, he stated that once deployed, the trellis 24/line 82 com-
`
`bination in DiMatteo must maintain a perfectly circular shape. Response to Petition at
`
`35-36. This means it must be rigid. Id. Otherwise, if the trellis 24/liner 82 com-
`
`bination is malleable/pliable when deployed, it will conform to the irregular shape of
`
`the aortic wall and the valve leaflets will misalign. Id. (See also Ex. 1009, 247:11-
`
`248:12; Ex. 2133 (illustration).)
`
`III. Norred Provided Support for the Substitute Claim
`
`The ‘228 patent is not limited to prosthetic valves incorporating balloon-
`
` 2
`
`
`
`
`
`expandable stents. While the specification discusses the use of a balloon to place the
`
`valve prosthesis (Ex. 1001, 2:61-3:12), this is merely a method of placement. It is not
`
`a description of the device being placed. The device being placed is described as a
`
`“stent system made up of a small slotted stainless tube or series of interconnected
`
`rods which form an expandable lattice or scaffolding” (Ex. 1001, 2:61-63). Both bal-
`
`loon-expandable and self-expanding stents can be constructed in such manner (see gen-
`
`erally Ex. 1008, 1:59-6:21).
`
`The stent system is incorporated into claims 19 and 20 through the means-plus-
`
`function language. The combination of rods 104 interacting with stent 28 is the struc-
`
`ture that maintains the ring member against the aortic wall. Paper 10 at 10. This is
`
`what makes the valve prosthesis operable and is an integral part of Norred’s inven-
`
`tion. (See Ex. 1001, Abstract, 1:6-10, 29-31, 2:62-63, 3:1-45, Figs. 1-5.)
`
`IV. Norred Showed that the Substitute Claim Is Patentable
`
`Norred studied 33 prior art references for his Motion to Amend. None of
`
`them anchor in place through a means of a stent system that extends into the ascend-
`
`ing aorta, as is required by Claim 25. Instead, in almost all cases where a stent is used,
`
`it is confined to the native annulus. (See, e.g., Exs. 2116, 2122 & 2123). These “short
`
`stent” designs cannot displace aortic pressure in a manner mimicking the native valve.
`
`(Ex. 2095, ¶ 31; Ex. 2093, ¶ 80.) Only one prior art reference describes a longer stent
`
`(Ex. 1013), and in that case, the stent relies upon barbs to anchor it to the aortic wall,
`
`creating a risk of aortic dissection and infection. (Ex. 2095, ¶ 48; Ex. 2093, ¶ 73.)
`
` 3
`
`
`
`
`
`Similarly, none of the prior art references incorporate a ring member having a
`
`pliable circumference adapted to seat about an aortic wall surrounding an aortic chan-
`
`nel and seal against a root of a native aortic valve upon percutaneous placement. In-
`
`stead, in cases where a ring member of some sort is used, it is not pliable (see, e.g., Exs.
`
`2113 & 2114), it will not seal (see, e.g., Exs. 2099 & 2119), or it will not seal upon per-
`
`cutaneous placement (see, e.g., Exs. 2101 & 2102). These differences are functionally
`
`significant. (Ex. 2095, ¶¶ 28, 32 & 33.)
`
`It is not possible to combine these prior art references to create the device de-
`
`scribed in Claim 25 because vital elements—the stent and ring member—are wholly
`
`absent. Prior to the ‘228 Patent, there was nothing in the art that taught or suggested
`
`a valve prosthesis that could be held in place with the stent alone and displace aortic
`
`pressure in a manner mimicking the native valve, and that incorporated a ring member
`
`having a pliable circumference adapted to seat about an aortic wall surrounding an
`
`aortic channel and seal against the root of a native aortic valve upon percutaneous
`
`placement. (See Ex. 2095, ¶¶ 31, 40-51; Ex. 2093, ¶¶62, 73, 74, 80.)
`
`In opposing Norred’s Motion to Amend, Petitioner highlights four prior art
`
`references as purportedly significant: Figulla (Ex. 1013), Fraunhofer (Ex. 2126),
`
`Schreck (Ex. 2098) and DiMatteo (Ex. 1003). Figulla incorporates a stent that extends
`
`into the ascending aorta, but it anchors to the aortic wall with barbs and has no ring
`
`member. (Ex. 1013, Fig. 2.) Fraunhofer and Schreck have “short stent” designs, not
`
`the stent required by Claim 25, and rely upon hooks or barbs to attach to the aortic
`
` 4
`
`
`
`
`
`wall. (Ex. 2126, p. 3, ll. 41-49, p. 4, ll. 1-5; Ex. 2098, 13:29-31, 13:63-14:5, 15:7-11,
`
`Fig. 16C.) Fraunhofer does not include a ring member. Schreck has a structure that
`
`could serve as a ring member, but its “short stent” design and elongated commissure
`
`posts compromises its ability to seal against root of the native valve. (Ex. 2098, Figs.
`
`6 & 7; Exs. 2129, 2130 & 2131; Ex. 1009, 249:6-255:16.) DiMatteo’s purported ring
`
`member must be rigid, rather than pliable, so it maintains its circular shape upon
`
`placement, allowing the valve leaflets to properly align. (Exs. 2132, 2133 & 2134; Ex.
`
`1009, 245:14-248:12.) None of these prior art references, alone or in combination,
`
`contain the elements of Claim 25.
`
`While several surgically implanted devices incorporate pliable rings (see, e.g.,
`
`Exs. 2010 & 2102), these rings are not adapted to seal against the root of the native
`
`valve upon percutaneous placement. Instead, they are designed to hold sutures. (See,
`
`e.g., Ex. 2102, 4:77-18, 6:50-7:5.) The sutures pull the ring and the surrounding tissue
`
`together to create a seal. See id. It would not have been obvious to incorporate these
`
`“sewing” rings into a valve design where sutures are not used. The idea that a seal
`
`could be created without sutures, through radial force alone, was wholly novel.
`
`Respectfully Submitted,
`
`ERICKSON KERNELL
`DERUSSEAU & KLEYPAS, LLC
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ James J. Kernell
`James J. Kernell, Reg. No. 42720
`Phone: (913) 549-4700 Fax: (913) 549-4646
`
` 5
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify this November 24, 2014, that the foregoing Patent Owner Re-
`
`ply in Support of Motion to Amend has been served electronically through the Patent
`
`Trial and Appeals Board’s Patent Review Processing System (PRPS) upon the lead
`
`and back-up counsel for the Petitioner, JACK BARUFKA, 1650 Tysons Boulevard,
`
`McLean, Virginia 22102; and EVAN FINKEL, 725 South Figeuroa Street, Suite 2700,
`
`Los Angeles, California 90017, both of Pillsbury Winthrop Shaw Pittman LLP.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ James J. Kernell
`Attorney for Patent Owner
`
`
`
` 6
`
`